Concord Biotech Cash Flow Annual

Trade
BSE: 543960 | NSE: CONCORDBIO | ISIN: INE338H01029 | Sector: -
2,073.30 +41.75 (2.06%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 412.57322.01237.52312.72
Depreciation/ Depletion 53.5954.0350.0527.52
Non- Cash Items -16.16-5.192.75-9.49
Changesin Working Capital -184.53-124.86-82.84-163.94
Cashfrom Operating Activities 265.47246.00207.48166.82
Capital Expenditures -85.69-145.08-155.51-204.18
Other Investing Cash Flow Items Total -68.92-12.8743.728.97
Cashfrom Investing Activities -154.61-157.95-111.79-195.21
Financing Cash Flow Items -1.26-4.88-72.75-5.71
Total Cash Dividends Paid -71.45-53.56--
Issuance( Retirement)of Debt Net -26.50-26.78-27.4236.83
Cashfrom Financing Activities -99.21-85.22-100.1631.12
Net Changein Cash 11.642.83-4.482.74
Cash Interest Paid 2.653.785.320.00
Cash Taxes Paid 103.3570.2860.7975.18
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts